AU2002364594A1 - Medicinal aerosol compositions with an amide and/or ester containing excipient compound - Google Patents
Medicinal aerosol compositions with an amide and/or ester containing excipient compound Download PDFInfo
- Publication number
- AU2002364594A1 AU2002364594A1 AU2002364594A AU2002364594A AU2002364594A1 AU 2002364594 A1 AU2002364594 A1 AU 2002364594A1 AU 2002364594 A AU2002364594 A AU 2002364594A AU 2002364594 A AU2002364594 A AU 2002364594A AU 2002364594 A1 AU2002364594 A1 AU 2002364594A1
- Authority
- AU
- Australia
- Prior art keywords
- group
- drug
- excipient
- medicinal
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34262301P | 2001-12-21 | 2001-12-21 | |
| US60/342,623 | 2001-12-21 | ||
| PCT/US2002/041251 WO2003059331A2 (en) | 2001-12-21 | 2002-12-20 | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002364594A1 true AU2002364594A1 (en) | 2003-07-30 |
Family
ID=23342584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002364594A Abandoned AU2002364594A1 (en) | 2001-12-21 | 2002-12-20 | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7186402B2 (enExample) |
| EP (1) | EP1455764B1 (enExample) |
| JP (1) | JP2005514440A (enExample) |
| AT (1) | ATE406152T1 (enExample) |
| AU (1) | AU2002364594A1 (enExample) |
| CA (1) | CA2470498A1 (enExample) |
| DE (1) | DE60228615D1 (enExample) |
| WO (1) | WO2003059331A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1458354A1 (en) * | 2001-12-21 | 2004-09-22 | 3M Innovative Properties Company | Medicinal aerosol formulations comprising ion pair complexes |
| CA2470498A1 (en) | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| EP1458357B1 (en) * | 2001-12-21 | 2009-03-04 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| WO2005032521A2 (en) * | 2003-10-02 | 2005-04-14 | Collegium Pharmaceutical, Inc. | Non-flammable topical anesthetic liquid aerosols |
| US20060188449A1 (en) * | 2003-10-03 | 2006-08-24 | Jane Hirsh | Topical aerosol foams |
| WO2005115336A2 (en) * | 2004-05-15 | 2005-12-08 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
| GB0614621D0 (en) | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
| GB0620700D0 (en) | 2006-10-19 | 2006-11-29 | 3M Innovative Properties Co | Metered dose valves and dispensers |
| US8652443B2 (en) * | 2008-02-14 | 2014-02-18 | Precision Dermatology, Inc. | Foamable microemulsion compositions for topical administration |
| GB201118188D0 (en) | 2011-10-21 | 2011-12-07 | 3M Innovative Properties Co | Manufacture of medicinal aerosol canisters |
| GB201210580D0 (en) | 2012-06-14 | 2012-08-01 | 3M Innovative Properties Co | Metered dose dispensing valve |
| GB201221063D0 (en) | 2012-11-23 | 2013-01-09 | 3M Innovative Properties Co | Metered dose dispensing valve |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| WO1994008599A1 (en) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| ES2129117T3 (es) | 1992-12-09 | 1999-06-01 | Boehringer Ingelheim Pharma | Formulaciones en disolucion en forma de aerosol medicinales estabilizadas. |
| KR100321649B1 (ko) | 1993-03-17 | 2002-07-22 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제 |
| DE69405719T2 (de) | 1993-03-17 | 1998-01-15 | Minnesota Mining & Mfg | Aerosolzubereitung, enthaltend ein aus einem diol-disäure-derivat abgeleitetes dispergiermittel |
| US5492688A (en) | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
| JPH09506097A (ja) | 1993-12-02 | 1997-06-17 | アボツト・ラボラトリーズ | 非ｃｆｃ噴射剤と共に用いるエアロゾル薬物調剤 |
| US5508023A (en) | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US6218353B1 (en) | 1997-08-27 | 2001-04-17 | Micell Technologies, Inc. | Solid particulate propellant systems and aerosol containers employing the same |
| US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
| BR9914799A (pt) | 1998-10-27 | 2001-07-10 | Alcon Lab Inc | Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido |
| US6258857B1 (en) * | 1999-02-04 | 2001-07-10 | Kyowa Industrial Co., Ltd. | Internal liquid composition contained as internal liquid in a releasing container and releasing container product |
| JP2003535122A (ja) | 2000-06-02 | 2003-11-25 | ザイコス インク． | 生物活性物質のための送達システム |
| EP1458354A1 (en) * | 2001-12-21 | 2004-09-22 | 3M Innovative Properties Company | Medicinal aerosol formulations comprising ion pair complexes |
| EP1458357B1 (en) * | 2001-12-21 | 2009-03-04 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| CA2470498A1 (en) | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
-
2002
- 2002-12-20 CA CA002470498A patent/CA2470498A1/en not_active Abandoned
- 2002-12-20 AU AU2002364594A patent/AU2002364594A1/en not_active Abandoned
- 2002-12-20 AT AT02799975T patent/ATE406152T1/de not_active IP Right Cessation
- 2002-12-20 EP EP02799975A patent/EP1455764B1/en not_active Expired - Lifetime
- 2002-12-20 US US10/327,198 patent/US7186402B2/en not_active Expired - Fee Related
- 2002-12-20 WO PCT/US2002/041251 patent/WO2003059331A2/en not_active Ceased
- 2002-12-20 JP JP2003559494A patent/JP2005514440A/ja not_active Withdrawn
- 2002-12-20 DE DE60228615T patent/DE60228615D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7186402B2 (en) | 2007-03-06 |
| WO2003059331A2 (en) | 2003-07-24 |
| ATE406152T1 (de) | 2008-09-15 |
| CA2470498A1 (en) | 2003-07-24 |
| EP1455764A2 (en) | 2004-09-15 |
| JP2005514440A (ja) | 2005-05-19 |
| US20030138381A1 (en) | 2003-07-24 |
| WO2003059331A3 (en) | 2003-11-20 |
| EP1455764B1 (en) | 2008-08-27 |
| DE60228615D1 (de) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2344816C (en) | Medicinal aerosol formulation | |
| EP0731688B1 (en) | Aerosol drug formulations for use with non-cfc propellants | |
| CA2352483C (en) | Pharmaceutical aerosol composition containing hfa 227 and hfa 134a | |
| SK284430B6 (sk) | Farmaceutický prostriedok na použitie v aerosólovom inhalátore, aerosólový inhalátor a spôsob plnenia aerosólového inhalátora | |
| US7186402B2 (en) | Medicinal aerosol compositions with an amide and/or ester containing excipient compound | |
| EP2501363B1 (en) | Inhalation solutions | |
| AU2002367032B8 (en) | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient | |
| AU709783B2 (en) | Aerosol drug formulations containing vitamin E | |
| NZ501672A (en) | Proliposome powders for inhalation stabilised by racemic alpha-tocopherol | |
| US20030147814A1 (en) | Medicinal aerosol formulations comprising ion pair complexes | |
| EP1198224A1 (en) | Formulations of steroid solutions for inhalatory administration | |
| MXPA96004004A (en) | Formulations of aerosol drugs containing vitamin | |
| HK1176290B (en) | Inhalation solutions | |
| HK1097777B (en) | Medicinal aerosol formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |